Director Microbiology
Shionogi Inc.
Dr. DeJonge obtained his PhD at the University of Amsterdam and did his post-doctoral studies at the Rockefeller University in New York City, which led to an appointment as Research Assistant Professor. He subsequently worked at AstraZeneca, Pfizer, X-Biotix and ContaFect on the discovery and development of novel antibacterial agents. He is currently employed at Shionogi Inc. and works on cefiderocol.